Figure 1.
Figure 1. CMV-specific T-cell immune reconstitution and viral reactivation in HSCT patients. Longitudinal blood samples from HSCT recipients were monitored for viral reactivation and assessed for CMV-specific T-cell immunity using QuantiFERON and HLA-matched MHC-multimer analysis. (A-B) Representative MHC-multimer analyses from a NIR patient (p14) (A) and IR patient (p01) (B) are shown. Longitudinal analysis of viral load, MHC-multimer frequency, and QuantiFERON response in 2 NIR patients (p15 and p13) (A) and 2 IR patients (p01 and p15) (B) are shown. (C) Comparative analysis of the QuantiFERON IFN response and MHC-multimer frequency in IR (blue) and NIR (green) patients at 10 to 14 weeks after transplant. Linear regression lines and coefficient of determination (R2) are shown, and patients used for RNA-seq are annotated.

CMV-specific T-cell immune reconstitution and viral reactivation in HSCT patients. Longitudinal blood samples from HSCT recipients were monitored for viral reactivation and assessed for CMV-specific T-cell immunity using QuantiFERON and HLA-matched MHC-multimer analysis. (A-B) Representative MHC-multimer analyses from a NIR patient (p14) (A) and IR patient (p01) (B) are shown. Longitudinal analysis of viral load, MHC-multimer frequency, and QuantiFERON response in 2 NIR patients (p15 and p13) (A) and 2 IR patients (p01 and p15) (B) are shown. (C) Comparative analysis of the QuantiFERON IFN response and MHC-multimer frequency in IR (blue) and NIR (green) patients at 10 to 14 weeks after transplant. Linear regression lines and coefficient of determination (R2) are shown, and patients used for RNA-seq are annotated.

Close Modal

or Create an Account

Close Modal
Close Modal